JP Morgan Chase’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,500
Closed -$3.2M 7525
2025
Q4
$3.2M Buy
+17,500
New +$2.44M ﹤0.01% 3710
2025
Q3
Sell
-12,100
Closed -$1.26M 7384
2025
Q2
$1.26M Sell
12,100
-53,300
-81% -$5.64M ﹤0.01% 4235
2025
Q1
$7.63M Buy
65,400
+31,400
+92% +$3.58M ﹤0.01% 2780
2024
Q4
$2.88M Buy
+34,000
New +$3.13M ﹤0.01% 3869
2023
Q3
Sell
-4,000
Closed -$287K 7455
2023
Q2
$287K Buy
+4,000
New +$295K ﹤0.01% 4850
2023
Q1
Sell
-59,200
Closed -$4.57M 6684
2022
Q4
$4.57M Buy
59,200
+17,300
+41% +$1.03M ﹤0.01% 2894
2022
Q3
$1.87M Buy
+41,900
New +$2.09M ﹤0.01% 3531
2020
Q2
Sell
-50,000
Closed -$2.94M 5363
2020
Q1
$2.94M Buy
+50,000
New +$4.07M ﹤0.01% 2678
2019
Q3
Sell
-50,000
Closed -$1.27M 5712
2019
Q2
$1.27M Buy
+50,000
New +$1M ﹤0.01% 3695

Other funds holding AXSM